Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Acquisitions & Divestments (2016 - 2023)

Cartesian Therapeutics (RNAC) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $28.3 million as the latest value for Q1 2023.

  • For Q1 2023, Change in Acquisitions & Divestments rose 182.54% year-over-year to $28.3 million; the TTM value through Dec 2023 reached $28.3 million, up 43.42%, while the annual FY2023 figure was $28.3 million, 43.42% up from the prior year.
  • Change in Acquisitions & Divestments hit $28.3 million in Q1 2023 for Cartesian Therapeutics, up from $5.7 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $28.3 million in Q1 2023 and bottomed at $2.0 million in Q1 2019.
  • Average Change in Acquisitions & Divestments over 4 years is $10.1 million, with a median of $8.2 million recorded in 2021.
  • Year-over-year, Change in Acquisitions & Divestments crashed 86.76% in 2019 and then skyrocketed 182.54% in 2023.
  • Cartesian Therapeutics' Change in Acquisitions & Divestments stood at $14.4 million in 2019, then plummeted by 30.35% to $10.0 million in 2021, then plummeted by 43.0% to $5.7 million in 2022, then soared by 395.68% to $28.3 million in 2023.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $28.3 million, $5.7 million, and $4.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.